We are excited for the opportunity to connect and collaborate at the upcoming American Society of Retina Specialists annual meeting in Seattle this week! Drop by booth #515 and meet us in person. See you there!
#asrs#retinaspecialist#diabeticretinopathy#aiforhealth#eyeart
Eyenuk received FDA clearance to use an additional retinal camera for the detection of diabetic retinopathy (DR) that is easier to use and make it easier for primary care clinics to adopt the technology.
Read More: https://t.co/OL3eKe2O6t
@EyenukInc
BREAKING NEWS: @EyenukInc has been approved to market its EyeArt AI eye screening system in the European Union for the new uses of detecting AMD and glaucomatous optic nerve damage. #Ophthalmology#AMD#Glaucoma https://t.co/PntXFgohzB
Check out this podcast that discusses the EyeArt AI system and the use of autonomous AI in screening for diabetic retinopathy, featuring @JenniferLimMD from @UIHealth. https://t.co/NMnbA9Nrv2
This is where @RetinaGlobal1 comes in, which has supported AI development with multiple companies, managed validation studies, and provides the last mile benefit to patients, including in partnership with @EyenukInc, Inc. in its @OCEyeProject.
On World Diabetes Day, @EyenukInc recognizes Endocrine Associates of West Village for launching the EyeArt AI system for diabetic retinopathy screening. This implementation marks the first endocrinology practice in New York to adopt autonomous AI for diabetic eye testing.
Visit @EyenukInc this week to learn more about our #EyeArt#AI system for #diabeticretinopathy testing. You can find us in Booth 426 at the @NAMCP Fall Managed Care Forum in Las Vegas, NV and Booth 116 at The @RetinaSociety meeting in Pasadena, CA.
Check out the latest edition of @RetinalPhys magazine, where the #EyeArt system is featured in a cover story titled "Artificial Intelligence for the Screening of Diabetic Retinopathy." https://t.co/H0aRiTjpE8 #ai#medtech#diabetescare
.@EyenukInc announces it has secured $26 million in a Series A financing round, bringing the company’s total funding to over $43 million. https://t.co/dWlvPKn9FC
@EyenukInc is proud to announce we are selected from hundreds of competing companies as a Rising Star Finalist for a @ucsfhealthaward! Join us for a conversation with the finalists, Thursday 10/27 at 11 am PT on Zoom. Registration link: https://t.co/R5YjfkIm3H #DHA2022
All eyes are on Eyenuk, now that it has more than doubled its lifetime fundraising and plans to bring its diagnostic AI to even more conditions.
https://t.co/KjRFcfUr2P
Eyenuk today announced it has secured $26 million in a Series A financing round, bringing the company’s total funding to over $43 million. #Ophthalmology https://t.co/xGrSPULK47
On World Sight Day, @EyenukInc is proud to join @IAPB1 in raising awareness of the importance of regular eye exams. #LoveYourEyes, get your eyes checked, and spread the word to friends and family.